These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14991239)

  • 1. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
    Ramanathapuram LV; Kobie JJ; Bearss D; Payne CM; Trevor KT; Akporiaye ET
    Cancer Immunol Immunother; 2004 Jul; 53(7):580-8. PubMed ID: 14991239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
    Ramanathapuram LV; Hahn T; Graner MW; Katsanis E; Akporiaye ET
    Cancer Immunol Immunother; 2006 Feb; 55(2):166-77. PubMed ID: 16041582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination.
    Ramanathapuram LV; Hahn T; Dial SM; Akporiaye ET
    Nutr Cancer; 2005; 53(2):177-93. PubMed ID: 16573379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocotrienols are good adjuvants for developing cancer vaccines.
    Hafid SR; Radhakrishnan AK; Nesaretnam K
    BMC Cancer; 2010 Jan; 10():5. PubMed ID: 20051142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
    Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
    Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic immune response induced by electrofusion of dendritic and tumor cells.
    Tanaka H; Shimizu K; Hayashi T; Shu S
    Cell Immunol; 2002 Nov; 220(1):1-12. PubMed ID: 12718934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
    Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
    Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.
    Zhang M; Yin T; Lu Y; Feng H
    Med Sci Monit; 2016 Apr; 22():1309-17. PubMed ID: 27092689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer.
    Hahn T; Alvarez I; Kobie JJ; Ramanathapuram L; Dial S; Fulton A; Besselsen D; Walker E; Akporiaye ET
    Int J Cancer; 2006 May; 118(9):2220-31. PubMed ID: 16331615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.
    Sun QF; Zhao XN; Peng CL; Hao YT; Zhao YP; Jiang N; Xue H; Guo JZ; Yun CH; Cong B; Zhao XG
    Oncol Rep; 2015 Nov; 34(5):2289-95. PubMed ID: 26323510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dendritic cell-tumor cell fusion vaccine prevents growth of subcutaneous transplanted esophageal carcinomas].
    Deng YJ; Zhang LJ; Su XD; Zhang DK; Rong TH; Wang QJ; Xia JC
    Ai Zheng; 2009 Oct; 28(10):1067-71. PubMed ID: 19799815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
    Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
    Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
    Alteber Z; Azulay M; Cafri G; Vadai E; Tzehoval E; Eisenbach L
    Cancer Immunol Immunother; 2014 Apr; 63(4):369-80. PubMed ID: 24452202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
    Ou X; Cai S; Liu P; Zeng J; He Y; Wu X; Du J
    J Cancer Res Clin Oncol; 2008 May; 134(5):525-33. PubMed ID: 17909857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.
    Zhang W; He L; Yuan Z; Xie Z; Wang J; Hamada H; Cao X
    Hum Gene Ther; 1999 May; 10(7):1151-61. PubMed ID: 10340547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.